Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to attend the following events in May 2019:
Conference details:
5th Annual SunTrust Robinson Humphrey (STRH) Life Sciences Summit
Date: Wednesday, May 8, 2019
Location: New York, NY
CAR-T and The Rise of the Cellicon Valley
Date: Friday, May 10, 2019
Presentation Time: 3:30 p.m. EDT
Location: Philadelphia, PA
Sachs 5th Annual Immuno-Oncology BD&L and Investment Forum
Date: Friday, May 31, 2019
Presentation Time: 11:50 a.m. EDT
Location: Chicago, IL
